24-dehydrocholesterol reductase (DHCR24), another critical biosynthetic enzyme, is effectively targeted by hucMSC-sEV-delivered miR-370-3p, which suppresses cervical cancer progression via cholesterol homeostasis disruption [60]. This evidence concerns the gene DHCR24 and cervical carcinoma.